A disease of breast tissue, with diverse subtypes and risk factors.
A BBC report highlights ongoing struggles with complex menopause after cancer treatment. A pilot clinic in Sussex aims to provide tailored menopause support for breast cancer patients, while patients urge earlier discussion of menopause as a treatment side effect. The Guardian notes baxdrostat’s potential to reduce blood pressure in primary aldosteronism, with long-term effects still being studied.
Lucy Davis has disclosed a Stage 4 breast cancer diagnosis that has metastasised to her bones. She states the cancer is incurable and that chemotherapy is no longer an option. She will continue living as fully as possible while seeking privacy for her family.
Lucy Davis has revealed an incurable breast cancer diagnosis with metastasis to her bones. She has thanked fans for support and shared a light moment skateboarding to show she remains positive. The message has drawn messages of love from fellow actors and family.
A wave of studies finds that AI analysis of mammograms can identify cardiovascular risks in women, including hypertension, coronary heart disease and stroke, alongside breast cancer screening. Researchers say mammograms could become a dual-purpose tool for early cardiovascular risk detection, prompting earlier intervention.
Fernandes has broken the Premier League assists record with 21 assists and scored nine goals as Manchester United finish third. Shaw has top-scored for City with 21 goals as they win the Women’s Super League. The awards are decided by the Football Writers’ Association and PFA, with additional honours for players across Arsenal, City and United. The teams also celebrate multiple winners and a host of youth awards.
The FDA has approved daraxonrasib, sold as Rasonque by Revolution Medicines, for adults with previously treated or ineligible metastatic pancreatic cancer. Clinical trials have shown median survival extended to about 13.2 months versus roughly 6.7 months with chemotherapy. The drug will be available in the US with a roughly $39,800 monthly list price and expanded-access programmes have already treated thousands.
Dame Jenni Murray, longtime BBC Radio 4 presenter of Woman’s Hour, has died after a March crash in north London. An inquest has ruled bronchopneumonia caused by rib and sternum fractures sustained in the collision as the cause of death. She dies following a career spanning decades and a damehood in 2011.
GLP-1 medications are being increasingly prescribed off-label to children aged 8–11 in the US, despite no FDA approval for under-12s. A NYU Langone study shows a dramatic rise in June 2026, while experts warn about long-term effects and the broader obesity crisis.
A group of cancer patients and survivors are turning to AI and technology to manage treatment, track symptoms, and fundraise. Stories span colon cancer under 50, breast cancer with brain tumors, uterus cancer, and chemotherapy's real-life impact, highlighting personal strategies and community support.
BBC presenter has polycythemia vera, an incurable yet manageable blood cancer diagnosed in 2024. She continues reporting while undergoing treatment and advocates awareness through Blood Cancer UK.
Three BBC investigations have revealed repeated failures in UK cancer care: a final review has found harm from misdiagnosis and inappropriate treatment by former Belfast neurologist Michael Watt; Coventry patients were prescribed temozolomide for years with little evidence of benefit; and England is missing cancer-treatment targets, with only 69.9% starting within 62 days. Officials and families are demanding answers.
A public look-back into CDDFT’s breast unit has harmed hundreds of patients, with 315 identified as harmed and 77 significantly harmed. The NHS and BBC reporting have prompted a potential extension to cases dating back to 2015. A board meeting today will decide the scope and timeframe as authorities consider further inquiries and safeguards.
A new analysis shows a rise in cancers among people under 50 across England, the US and the Netherlands, driven by obesity, diet and lifestyle factors, with bowel, kidney and uterine cancers among the fastest-growing. Experts urge research and prevention as diagnosis at younger ages becomes more common.
Three unrelated stories highlight breast and ovarian cancer issues: a man’s mastectomy after a pre-cancerous lump, a woman’s late-stage ovarian cancer linked to coil pain, and a breast-cancer relapse detected by a spouse. The reports underline awareness, timely checks, and treatment journeys across the UK and US.
Late-stage trials show sacituzumab tirumotecan improves median overall survival to 19 months versus 12.1 months with chemotherapy, but with notable side effects. New ovarian cancer therapy rinatabart sesutecan also demonstrates a strong progression-free survival benefit. Other programs in the field report positive results, signaling a robust biotech landscape but with continued safety concerns.